microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment

Abstract Introduction Human brucellosis is a zoonotic bacterial disease with up to 500,000 new cases each year. The major evasion mechanisms from the host immune system by Brucella are restraint of complement pathway and Toll‐like receptors signaling pathways, interference with efficient antigen pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sima Kazemi, Rasoul Mirzaei, Mohammad Sholeh, Sajad Karampoor, Fariba Keramat, Massoud Saidijam, Mohammad Yousef Alikhani
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/de310240b83a42ef9ef838a9790b8cae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de310240b83a42ef9ef838a9790b8cae
record_format dspace
spelling oai:doaj.org-article:de310240b83a42ef9ef838a9790b8cae2021-11-12T19:57:14ZmicroRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment2050-452710.1002/iid3.519https://doaj.org/article/de310240b83a42ef9ef838a9790b8cae2021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.519https://doaj.org/toc/2050-4527Abstract Introduction Human brucellosis is a zoonotic bacterial disease with up to 500,000 new cases each year. The major evasion mechanisms from the host immune system by Brucella are restraint of complement pathway and Toll‐like receptors signaling pathways, interference with efficient antigen presentation to CD4‐positive T lymphocytes, selective subversion of autophagy pathways, inhibition of dendritic cell stimulation, inhibition of autophagolysosomal fusion, and macrophage apoptosis. Many molecular and cellular pathways contribute to brucellosis that microRNAs have a vital function in the immunopathogenesis of this disease. In this regard, these molecules apply for their roles by modulating various events like inflammatory reactions and immune defense. Recently, in the case of immunity to human brucellosis, it has been shown that microRNAs play an important role in immunity against these bacteria. Methods and Results In this study, we tried to review the immune defense and immunopathogenesis of Brucella infection and highlight the current knowledge of the microRNAs in infected cells by Brucella pathogens. The recent findings suggest that the regulation of microRNAs expression is impaired during brucellosis infection, which may contribute to disease progression or inhibition by modulating immune responses against this pathogen. Conclusions The interplay between miRNAs and Brucella pathogens and the underlying process required comprehensive examination to unravel the novel therapeutic or diagnostic approaches.Sima KazemiRasoul MirzaeiMohammad SholehSajad KarampoorFariba KeramatMassoud SaidijamMohammad Yousef AlikhaniWileyarticlebiomarkerbrucellosisimmunopathogenesismicroRNAstherapeutic targetsImmunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1209-1218 (2021)
institution DOAJ
collection DOAJ
language EN
topic biomarker
brucellosis
immunopathogenesis
microRNAs
therapeutic targets
Immunologic diseases. Allergy
RC581-607
spellingShingle biomarker
brucellosis
immunopathogenesis
microRNAs
therapeutic targets
Immunologic diseases. Allergy
RC581-607
Sima Kazemi
Rasoul Mirzaei
Mohammad Sholeh
Sajad Karampoor
Fariba Keramat
Massoud Saidijam
Mohammad Yousef Alikhani
microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
description Abstract Introduction Human brucellosis is a zoonotic bacterial disease with up to 500,000 new cases each year. The major evasion mechanisms from the host immune system by Brucella are restraint of complement pathway and Toll‐like receptors signaling pathways, interference with efficient antigen presentation to CD4‐positive T lymphocytes, selective subversion of autophagy pathways, inhibition of dendritic cell stimulation, inhibition of autophagolysosomal fusion, and macrophage apoptosis. Many molecular and cellular pathways contribute to brucellosis that microRNAs have a vital function in the immunopathogenesis of this disease. In this regard, these molecules apply for their roles by modulating various events like inflammatory reactions and immune defense. Recently, in the case of immunity to human brucellosis, it has been shown that microRNAs play an important role in immunity against these bacteria. Methods and Results In this study, we tried to review the immune defense and immunopathogenesis of Brucella infection and highlight the current knowledge of the microRNAs in infected cells by Brucella pathogens. The recent findings suggest that the regulation of microRNAs expression is impaired during brucellosis infection, which may contribute to disease progression or inhibition by modulating immune responses against this pathogen. Conclusions The interplay between miRNAs and Brucella pathogens and the underlying process required comprehensive examination to unravel the novel therapeutic or diagnostic approaches.
format article
author Sima Kazemi
Rasoul Mirzaei
Mohammad Sholeh
Sajad Karampoor
Fariba Keramat
Massoud Saidijam
Mohammad Yousef Alikhani
author_facet Sima Kazemi
Rasoul Mirzaei
Mohammad Sholeh
Sajad Karampoor
Fariba Keramat
Massoud Saidijam
Mohammad Yousef Alikhani
author_sort Sima Kazemi
title microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
title_short microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
title_full microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
title_fullStr microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
title_full_unstemmed microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
title_sort micrornas in human brucellosis: a promising therapeutic approach and biomarker for diagnosis and treatment
publisher Wiley
publishDate 2021
url https://doaj.org/article/de310240b83a42ef9ef838a9790b8cae
work_keys_str_mv AT simakazemi micrornasinhumanbrucellosisapromisingtherapeuticapproachandbiomarkerfordiagnosisandtreatment
AT rasoulmirzaei micrornasinhumanbrucellosisapromisingtherapeuticapproachandbiomarkerfordiagnosisandtreatment
AT mohammadsholeh micrornasinhumanbrucellosisapromisingtherapeuticapproachandbiomarkerfordiagnosisandtreatment
AT sajadkarampoor micrornasinhumanbrucellosisapromisingtherapeuticapproachandbiomarkerfordiagnosisandtreatment
AT faribakeramat micrornasinhumanbrucellosisapromisingtherapeuticapproachandbiomarkerfordiagnosisandtreatment
AT massoudsaidijam micrornasinhumanbrucellosisapromisingtherapeuticapproachandbiomarkerfordiagnosisandtreatment
AT mohammadyousefalikhani micrornasinhumanbrucellosisapromisingtherapeuticapproachandbiomarkerfordiagnosisandtreatment
_version_ 1718430345728098304